# EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE
> **ANDA220511** · Abbreviated New Drug Application (Generic) · Sponsor: AJANTA PHARMA LTD · Approved 2026-02-25
## Drug
- **FDA Application Number:** ANDA220511
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE
- **Generic name:** Empagliflozin, Metformin Hydrochloride
- **Active ingredients:** EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** —
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** AJANTA PHARMA LTD
- **First approval:** 2026-02-25
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220511)
---
*AI Analytics · CC0 1.0*